Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
176 USD | +2.06% | +6.33% | -2.12% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.12% | 9.64B | |
-5.15% | 181B | |
+2.48% | 112B | |
-2.82% | 67.92B | |
+4.41% | 50.1B | |
+7.95% | 44.27B | |
+9.39% | 40.41B | |
+25.12% | 31.95B | |
-0.25% | 25.82B | |
+17.27% | 25.29B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Repligen Insider Sold Shares Worth $557,328, According to a Recent SEC Filing